Sort
15,842 grants matching “pancreatic cancer”
Allergies and pancreatic cancer: A pooled analysis in PANC4
$94,800Sara H Olson · Sloan-Kettering Inst Can Research · R03 · FY2009 · CA
Allergies and pancreatic cancer: A pooled analysis in PANC4
$94,800Sara H Olson · Sloan-Kettering Inst Can Research · R03 · FY2010 · CA
Are shared controls useful in genome-wide association studies for cancer genetic
$94,800Robert J. Klein · Sloan-Kettering Inst Can Research · R03 · FY2009 · CA
P-1: Immunotherapy of Pancreatic Adenocarcinoma
$94,756Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2008 · CA
The Extracellular Matrix in Muscle Atrophy
$94,716Erin E Talbert · Medical University Of South Carolina · K99 · FY2019 · AR
Developemental Research Program
$94,689Bert Vogelstein · Johns Hopkins University · P50 · FY2010 · CA
METABOLIC ENGINEERING OF REACTIVE GLYCOCONJUGATES
$94,605University Of California Berkeley · R01 · FY2005 · GM
Interrogating the RAS interactome for therapeutic vulnerabilities
$94,596Hema Adhikari · Duke University · K99 · FY2020 · CA
Career Enhancement Program
$94,583William E Gillanders · Washington University · P50 · FY2020 · CA
Stopped-flow spectrometer for analysis of reaction kinetics
$94,530Jeffrey S McFarlane · Fort Lewis College · R16 · FY2023 · GM
The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center
$94,500Darwin Lewis Conwell · Ohio State University · U01 · FY2021 · DK
Career Program
$94,411Scott E Kern · Johns Hopkins University · P50 · FY2016 · CA
mouse phenotyping
$94,348Susan E. Crawford · Northwestern University At Chicago · P30 · FY2009 · CA
The Extracellular Matrix in Muscle Atrophy
$94,239Erin E Talbert · Medical University Of South Carolina · K99 · FY2018 · AR
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
$94,087Rajesh Agarwal · University Of Colorado Denver · R01 · FY2017 · CA
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
$94,087Rajesh Agarwal · University Of Colorado Denver · R01 · FY2018 · CA
Enhancing Access in Pancreatic Cancer: Examining Facilitators and Barriers to Tertiary Referral for Complex Oncologic Surgical Care.
$94,040Chukwuma N Eruchalu · Massachusetts General Hospital · F32 · FY2025 · CA
Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
$94,000Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R03 · FY2024 · CA
Pancreatic adenocarcinoma secretome as a dynamic biomarker for patient stromal reprogramming efficacy
$94,000Paul Michael Campbell · Research Inst Of Fox Chase Can Ctr · R03 · FY2022 · CA
Pancreatic adenocarcinoma secretome as a dynamic biomarker for patient stromal reprogramming efficacy
$94,000Paul Michael Campbell · Research Inst Of Fox Chase Can Ctr · R03 · FY2023 · CA
Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
$94,000Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R03 · FY2025 · CA
The Role of Pim Kinases as a Novel Molecular Target in Pancreatic Cancer
$93,970Antonio Thomas Baines · North Carolina Central University · SC2 · FY2010 · CA
Modeling muscle wasting in cancer cachexia
$93,961Denis C Guttridge · Medical University Of South Carolina · R21 · FY2017 · AR
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$93,810Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2021 · DK
mouse phenotyping
$93,774Susan E. Crawford · Northwestern University At Chicago · P30 · FY2008 · CA